VC Playbook: Making Focus A Strategic Advantage
An Interview With Robert Tansley Of Cambridge Innovation Capital
Executive Summary
In this latest installment of In Vivo’s VC Playbook series, Robert Tansley, a partner at Cambridge Innovation Capital, explains the fund’s special arrangement in Cambridge, UK and how the young venture capital group expects to grow in the biotech sector – the imminent prospect of Brexit notwithstanding.